ClinicalTrials.Veeva

Menu

Efficacy Evaluation of Two Different Fluoride Applications

Ivoclar Vivadent logo

Ivoclar Vivadent

Status

Completed

Conditions

White Spot Lesion

Treatments

Device: Fluoride Application (Experimental Fluoride Application)
Device: Fluor Protector S

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT06131294
LL4470462

Details and patient eligibility

About

The goal of this clinical trial is to evaluate the remineralizing or preservative effect of two different fluoride-containing products. The main question aims to answer how the mineral content of the active white spot lesions change after the treatment with those two fluoride applications in a split-mouth design by measuring their mineral content via QLF technology.

Each patient will receive both treatments in a split-mouth design. It is comparison between an experimental fluoride application and Fluoride Protector S.

Enrollment

23 patients

Sex

All

Ages

13 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least two active non-cavitated white spot lesions on buccal surfaces of anterior teeth or premolars (ICDAS code 1 and 2; Nyvad score 1) in two different quadrants.
  • Age between 13 and 50 years
  • No untreated caries lesions or periodontal disease
  • No systematic disease or medication (such as antidepressants, antibiotics etc.) that affects salivary flow rate
  • Subjects claimed regular brushing at least twice a day
  • Subjects had to agree to keep the scheduled recall appointments for at least 1 year.

Exclusion criteria

  • Inactive non-cavitated lesions (Nyvad Score 4)
  • Lesions with microcavity, cavitation, chipping or discoloration
  • Lesions at buccal side of the molars
  • Lesions adjacent to restoration
  • Developmental white spot lesions such as enamel hypoplasia
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

23 participants in 2 patient groups

Expermental Fluoride Application
Experimental group
Description:
The two-step system, consisting of Component A (ammonium fluoride solution) and Component B (calcium fluoride application), will be applied once on the white spot lesions one.
Treatment:
Device: Fluoride Application (Experimental Fluoride Application)
Fluor Protector S
Active Comparator group
Description:
The ammonium fluoride gel will be applied once on the white spot lesions.
Treatment:
Device: Fluor Protector S

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems